Neoadjuvant Treatment With Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder

J Pediatr Hematol Oncol. 2016 Nov;38(8):e283-e285. doi: 10.1097/MPH.0000000000000604.

Abstract

Inflammatory myofibroblastic tumor (IMT), which expresses cyclooxygenase-2 (COX-2), can be effectively treated with COX-2 inhibitor. Here, we report a case of urinary bladder IMT in a 13-year-old boy. Although total cystectomy was initially planned for complete resection of the tumor, neoadjuvant treatment with COX-2 inhibitor and prednisolone reduced the size of the tumor and enabled complete resection of the tumor by partial cystectomy. Neoadjuvant treatment with COX-2 inhibitor and prednisolone for IMT of the bladder allowed a more conservative surgical procedure that preserved bladder function.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Conservative Treatment / methods
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Cystectomy / methods
  • Humans
  • Inflammation
  • Male
  • Neoadjuvant Therapy / methods*
  • Neoplasms, Muscle Tissue / pathology
  • Neoplasms, Muscle Tissue / surgery*
  • Prednisolone / therapeutic use*
  • Urinary Bladder Neoplasms / surgery*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Prednisolone